Performance Measures in Dose‐Finding Experiments

DOI10.1111/INSR.12363zbMath1528.62065OpenAlexW3008045665MaRDI QIDQ6085864

Fernando Plo, Nancy Flournoy, José A. Moler

Publication date: 12 December 2023

Published in: International Statistical Review (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1111/insr.12363

zbMATH Keywords

adaptive designsmaximum tolerated doseoptimal designsperformance criteria

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Point estimation (62F10)

Cites Work

• Unnamed Item
• Unnamed Item
• Unnamed Item
• Unnamed Item
• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• The treatment versus experimentation dilemma in dose finding studies
• Nonlinear sequential designs for logistic item response theory models with applications to computerized adaptive tests
• Optimal Bayesian-feasible dose escalation for cancer phase I trials
• Operating characteristics of the standard phase I clinical trial design.
• Adaptive clinical trial designs for phase I cancer studies
• Cumulative cohort design for dose-finding
• Dose finding in drug development.
• Optimal Design for Nonlinear Response Models
• Dose Finding Using the Biased Coin Up-and-Down Design and Isotonic Regression
• Design and Analysis of Phase I Clinical Trials
• Statistical Methods for Dose‐Finding Experiments
• Consistency of continual reassessment method under model misspecification
• Bias reduction of maximum likelihood estimates
• Optimal Designs for Dose–Response Models With Restricted Design Spaces

This page was built for publication: Performance Measures in Dose‐Finding Experiments